These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30244670)

  • 1. Open questions: CRISPR biology.
    Koonin EV
    BMC Biol; 2018 Sep; 16(1):95. PubMed ID: 30244670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas: biology, mechanisms and relevance.
    Hille F; Charpentier E
    Philos Trans R Soc Lond B Biol Sci; 2016 Nov; 371(1707):. PubMed ID: 27672148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of CRISPR-Cas systems in adaptive immunity and beyond.
    Barrangou R
    Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
    Westra ER; van Houte S; Gandon S; Whitaker R
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
    [No Abstract]   [Full Text] [Related]  

  • 5. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 6. CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases.
    Garcia-Robledo JE; Barrera MC; Tobón GJ
    Int Rev Immunol; 2020; 39(1):11-20. PubMed ID: 31625429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling immunity and programmed cell suicide in prokaryotes: Life-or-death choices.
    Koonin EV; Zhang F
    Bioessays; 2017 Jan; 39(1):1-9. PubMed ID: 27896818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
    Wright AV; Nuñez JK; Doudna JA
    Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokaryote autoimmunity in the context of self-targeting by CRISPR-Cas systems.
    Lenskaia T; Boley D
    J Bioinform Comput Biol; 2020 Oct; 18(5):2050033. PubMed ID: 33078994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas adaptation: insights into the mechanism of action.
    Amitai G; Sorek R
    Nat Rev Microbiol; 2016 Feb; 14(2):67-76. PubMed ID: 26751509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biology of CRISPR-Cas: Backward and Forward.
    Hille F; Richter H; Wong SP; Bratovič M; Ressel S; Charpentier E
    Cell; 2018 Mar; 172(6):1239-1259. PubMed ID: 29522745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.
    Kirchner M; Schneider S
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13508-14. PubMed ID: 26382836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.
    Makarova KS; Wolf YI; Iranzo J; Shmakov SA; Alkhnbashi OS; Brouns SJJ; Charpentier E; Cheng D; Haft DH; Horvath P; Moineau S; Mojica FJM; Scott D; Shah SA; Siksnys V; Terns MP; Venclovas Č; White MF; Yakunin AF; Yan W; Zhang F; Garrett RA; Backofen R; van der Oost J; Barrangou R; Koonin EV
    Nat Rev Microbiol; 2020 Feb; 18(2):67-83. PubMed ID: 31857715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subtype I-F CRISPR-Cas system influences pathogenicity island retention in Pectobacterium atrosepticum via crRNA generation and Csy complex formation.
    Richter C; Fineran PC
    Biochem Soc Trans; 2013 Dec; 41(6):1468-74. PubMed ID: 24256239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery of CRISPR in archaea and bacteria.
    Mojica FJ; Rodriguez-Valera F
    FEBS J; 2016 Sep; 283(17):3162-9. PubMed ID: 27234458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CRISPR: discovery, mechanism and function.
    Pawluk A; Davidson AR; Maxwell KL
    Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR-Cas systems as weapons against pathogenic bacteria].
    Bikard D; Barrangou R
    Biol Aujourdhui; 2017; 211(4):265-270. PubMed ID: 29956653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of discovery: CRISPR functions and applications.
    Barrangou R; Horvath P
    Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.